Invokana Wins F.D.A. Approval for Diabetes Treatment

Clinical trials for the drug, Invokana, showed that it improved patients’ blood-sugar levels and also led to weight loss and reductions in blood pressure.

Source: NYT Health - March 29, 2013 Category: Consumer Health News Authors: By KATIE THOMAS and ANDREW POLLACK Tags: Johnson & Johnson JNJ NYSE Drugs (Pharmaceuticals) Food and Drug Administration Wells Fargo Company WFC NYSE Invokana Diabetes Bristol Myers Squibb Company BMY NYSE Source Type: news